trending Market Intelligence /marketintelligence/en/news-insights/trending/QS_v-ntofSZya6xlLFcqsA2 content esgSubNav
Log in to other products


Looking for more?

Contact Us
In This List

ICON acquires majority stake in MeDiNova Research


COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021


Climate Credit Analytics: Linking climate scenarios to financial impacts


Global M&A Infographic Q1 2021


Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

ICON acquires majority stake in MeDiNova Research

ICON PLC, a clinical research organization, acquired a majority stake in West Midlands, U.K.-based MeDiNova Research.

MeDiNova Research operates a network of 33 research sites in Europe and Africa and provides investigator based clinical research services.

Dublin-based ICON is a tools and services company and provides drug development solutions and services to the pharmaceutical and biotechnology industry.

Under the transaction, ICON has the right to acquire the remaining shares of MeDiNova Research by the third quarter of 2020.

Financial terms of the transaction were not disclosed.